HBIO
HBIO
NASDAQ · Life Sciences Tools & Services

Harvard Bioscience Inc

$5.21
+0.34 (+6.98%)
As of Apr 1, 4:01 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +586.2% upside
Low Target $24.20
Average Target $35.75
High Target $46.73
Current Price $5.21
Current
$5.21
Target
$35.75
$24.20 $35.75 avg $46.73
Scenario Analysis
Bear Case
$24.20
364.5%
Low target
Base Case
$35.75
+586.2%
Avg target
Bull Case
$46.73
+796.9%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$9.46
-44.9% from high
52-Week Low
$2.81
+85.4% from low
Target vs 52W High
$35.75
+277.9% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 33 88% $369.21 -25.3%
DHR
Danaher Corp
Strong Buy 30 87% $158.11 -17.1%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -43.5%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -51.9%
MTD
Mettler-Toledo International
Hold 21 43% $170.43 -86.6%
ILMN
Illumina Inc
Hold 28 54% $169.36 +33.7%
WAT
Waters Corp
Buy 28 57% $189.60 -36.8%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -46.1%